Andrea J. Bernhardy

Association of Trypanolytic ApoL1 Variants with Kidney Disease in African Americans

Giulio Genovese, David J. Friedman, Michael D. Ross et al. · Science · 2010 · 2K citations · Full text

Medicine, Genetics, Molecular Genetics +14

CDK12 Inhibition Reverses De Novo and Acquired PARP Inhibitor Resistance in BRCA Wild-Type and Mutated Models of Triple-Negative Breast Cancer

Shawn F. Johnson, Cristina Cruz, Ann Katrin Greifenberg et al. · Cell Reports · 2016 · 286 citations · Full text

Medicine, Cancer Biology, Oncology +16

The BRCA1-Δ11q Alternative Splice Isoform Bypasses Germline Mutations and Promotes Therapeutic Resistance to PARP Inhibition and Cisplatin

Yifan Wang, Andrea J. Bernhardy, Cristina Cruz et al. · Cancer Research · 2016 · 271 citations · Full text

Medicine, Genetics, Oncology +16

Stabilization of mutant BRCA1 protein confers PARP inhibitor and platinum resistance

Neil Johnson, Shawn F. Johnson, Wei Yao et al. · Proceedings of the National Academy of Sciences · 2013 · 265 citations · Full text

Medicine, Molecular Biology, Oncology +15

The APOL1 Genotype of African American Kidney Transplant Recipients Does Not Impact 5-Year Allograft Survival

B.T Lee, Vineeta Kumar, Tom A. Williams et al. · American Journal of Transplantation · 2012 · 182 citations · Full text

Medicine, Genetics, Molecular Genetics +16